Galanin (1-15) Porcine, Rat
GWTLNSAGYLLGPHA -amide
Description
Application Data
Description
-
An N-terminal fragment of galanin (1-15); galanin is a widely distributed neuropeptide with a wide variety of roles including weight management and mental health.
Application Data
-
Catalogue number crb1000400 Molecular Weight 1554.8 Sequence (one letter code) GWTLNSAGYLLGPHA -amide
Sequence (three letter code) H-Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-His-Ala-NH2
Purity >95% cas 112747-70-3 References Narváez et al., (2000). The galanin receptor antagonist M40 blocks the central cardiovascular actions of the galanin N-terminal fragment (1-15). Eur J Pharmacol., 399(2): 197. PMID: 10884520.
Ruczynsk et al., (2002). Effects of porcine galanin, galanin (1–15) NH2 and its new analogues on glucose-induced insulin secretion. Pol J Pharmacol, 54(2): 133.
Manufactured in: United Kingdom Galanin is a widely distributed neuropeptide in the central nervous system (CNS), peripheral regions and endocrine system. Galanin interacts with 3 receptor subtypes, GalR1-3 G protein-coupled receptors inserted into the plasma membrane. Galanin has a role in energy homeostasis. Central injections of galanin to the amygdala led to food intake in rats. Galanin also acts in the CNS to inhibit neurotransmitter release, such as acetylcholine. Galanin has been implicated in numerous neurological conditions, including Alzheimer’s disease, depression, and epilepsy. A better understanding of the galinergic signalling pathways may uncover a source for therapeutics for conditions such as epilepsy.
Unlike human galanin, full-length porcine galanin contains only 29 amino acids and is C-terminally amidated. The first 15 residues are still highly conserved. The best-recognized effect of galanin on the endocrine pancreas is the inhibition of insulin secretion in vitro and in vivo on multiple model systems, including rats, dogs, and mice. However, the same effect cannot be achieved at the same concentrations in human models with infusions of porcine galanin. Structural activity and point mutation studies show that the N-terminal (1-15) fragment is vital for the interaction/activation of the GAL receptor and the inhibition of insulin secretion.
Galanin (1-15) Porcine, Rat
You may also like…
-
[5-FAM]-Galanin (2-30)-[Cys] (Human)
[5-FAM]-WTLNSAGYLLGPHAVGNHRSFSDKNGLTS-[C]-amide
View products -
Galanin (3-13)
TLNSAGYLLGP-amide
View products -
Galanin (1-13)
G-W-TLNSAGYLLGP-amide
View products -
Galanin (2-13) acid
WTLNSAGYLLGP-acid
View products -
Galanin (3-13)-Biotin
TLNSAGYLLGP-[Biotin]
View products -
Galanin Mouse, Rat
GWTLNSAGYLLGPHAIDNHRSFSDKHGLT-amide
View products -
Galanin (2-13)
WTLNSAGYLLGP-amide
View products -
Spexin
NWTPQAMLYLKGAQ-amide
View products -
Galanin (1-17) PorcineG-W-TLNSAGYLLGPHAID-amide
View products -
Galanin (2-13)-Biotin
WTLNSAGYLLGP-[Biotin]
View products -
[5-FAM]-Galanin (1-30) Human
[5-FAM]-GWTLNSAGYLLGPHAVGNHRSFSDKNGLTS-acid
View products -
Galanin (13-20) Mouse
PHAIDNHR-amide
View products -
Cys(BDP630/650)-Galanin (1-30) Human
[Cys(BDP630/650)]-GWTLNSAGYLLGPHAVGNHRSFSDKNGLTS-acid
View products -
[Cys]-Galanin (1-30) Human
[Cys]-GWTLNSAGYLLGPHAVGNHRSFSDKNGLTS-acid
View products -
Galanin Human
GWTLNSAGYLLGPHAVGNHRSFSDKNGLTS-acid
View products -
[5-TAMRA]-Galanin (1-30) Human
[5-TAMRA]-GWTLNSAGYLLGPHAVGNHRSFSDKNGLTS-acid
View products -
[5-TAMRA] Galanin, Human
[5-TAMRA]-GWTLNSAGYLLGPHAVGNHRSFSDKNGLTS-amide
View products -
Galanin (2-12) acid
WTLNSAGYLLG-acid
View products -
Galanin (2-30) acid
WTLNSAGYLLGPHAVGNHRSFSDKNGLTS-acid
View products